ACTRN12611000396921
Recruiting
未知
A randomised, double-blind, placebo controlled cross-over trial to measure the short and long term effects of wholegrain wheat breakfast cereals on biological markers, satiety and risk factors in adult males and females with overweight or obesity.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Biological responses in obesity following wheat breakfast cereals.
- Sponsor
- Victoria University
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Overweight or obesity confirmed by Body Mass Index \>25, and waist circumference \>80cm (females) and 94cm (males). The BMI used will be adjusted for ethnicity where appropriate. Participants will be otherwise deemed healthy.
Exclusion Criteria
- •Allergy to wheat, gluten, dairy or lactose.
- •Pregnancy or lactation.
- •Liver, kidney and heart disease.
- •Type 1 diabetes or type 2 diabetes with insulin medication.
- •Weight loss medication.
- •Participants that do not regularly consume breakfast or could not tolerate the same breakfast for the study period.
- •Unable to participate for the entire study period.
- •Excessive exercisers defined as significant levels of sport or strenuous leisure activity (30\-60 minutes 4\-5 times/week) or heavy occupational work (eg high performance athletes, farmers, construction workers, miners, forest workers).
- •Obesity caused by genetic factors or medication.
- •Neurological, endocrinological or other major systemic disease, including malignancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
The influence of ivabradine on the symptoms of neuropathic pain in a healthy volunteer pain model (IIVOP)europathic PainMedDRA version: 16.1Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2012-005627-32-GBCambridge University Hospitals NHS Foundation Trust and the University of Cambridge24
Completed
Phase 2
A double-blind, randomised, placebo controlled crossover study on the effects of 100mg, three times daily, Z-338 on the symptomatic response to a nutrient challenge and gasteric nutrient distribution and emptying in subjects with and without functional dyspepsia.Functional dyspepsiaOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12605000794606Zeria Pharmaceutical Co., Ltd52
Active, not recruiting
Phase 1
A randomised, double-blind, placebo-controlled crossover trial of the effects of metformin therapy on vascular and metabolic risk in young women with polycystic ovary syndrome. - Effects of metformin on vascular function in Polycystic Ovary SyndromePolycystic Ovary SyndromeEUCTR2005-005470-69-GBCardiff University36
Active, not recruiting
Not Applicable
A study to assess the effect of a single-does of VRP700 by inhalation to reduce the frequency and severity of cough in adults with Idiopathic Pulmonary Fibrosis (IPF)Chronic cough in Idiopathic Pulmonary FibrosisMedDRA version: 16.1Level: LLTClassification code 10066656Term: Chronic coughSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 16.1Level: PTClassification code 10011224Term: CoughSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2012-005794-31-GBVerona Pharma plc
Not yet recruiting
Not Applicable
Cranberry capsules for the prevention of urinary tract infection in an elderly populatioACTRN12605000626662Blue Care Research Unit120